Stroke (single) with resulting unilateral paresis.
Conditions
Interventions
The intervention consists of training for six weeks with Merlin for minimal 3 hours per week divided over minimally 4 to maximal 7 sessions. The time between training sessions should be at least 24 ho
Sponsors
UMCG
Eligibility
Inclusion criteria
Inclusion criteria: - 18 years or older - Unilateral paresis with at least some proximal voluntary movement capability (max FMA-UE = 50) - First incidence of single stroke or stuttering stroke - Minimal 6 months and maximal 3 years post-stroke - Able to perform finger extension 3 times - Ability to give informed consent, understand and execute simple instructions - Visual, mental and cognitive ability to assimilate and actively participate in the protocol - Being able to speak and understand Dutch/English - Know how to operate a computer (or have someone to help) and have the possibility to train at home.
Exclusion criteria
Exclusion criteria: - Multiple strokes or bilateral impairment - Inability to give informed consent - Moderate or severe cognitive impairment - Depression - Other medical disorders which could have effect on the results of the intervention such as rheumatic disorders or shoulder pain - Following occupational or physiotherapy specifically focussed on the arm/hand - Patients who have a positive predictor within 24 hours, such as wrist movement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wolf Motor Function Test (WMFT) | — |
Secondary
| Measure | Time frame |
|---|---|
| Action Research Arm Test (ARAT), Fugl-Meyer Assessment-Upper Extremity (FMA-UE), EuroQol-5D (EQ-5D), Intrinsic Motivation Inventory (IMI), System Usability Scale (SUS), Dutch Quebec User Evaluation of Satisfaction with Assistive Technology (D-QUEST) and biomechanical data using the ArmAssist Assessment (AAA) and Inertial Measurement Units (IMUs). Subjective opinion of the patient about the effectiveness and usability will be assessed during in-depth interviews. | — |
Contacts
Public ContactSamantha Rozevink
University Medical Centre Groningen
Outcome results
None listed